Atomoxetine is in a class of medications called selective noradrenaline reuptake inhibitors.
It is sold under a variety of brand names including Strattera®.
Atomoxetine is used as part of a total treatment programme to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD.
We are currently reviewing the research evidence on the use of atomoxetine for people with autism.
If you are aware of any research, or you would like to share your personal experiences of atomoxetine, please email email@example.com Thank you.
Please see the Advanced version of this page for more information about this intervention, including relevant research studies and details of how we will rank them.
Please read our Disclaimer about this intervention.
Last Updated : 19/04/2013 Back to Top